Skip to search formSkip to main contentSkip to account menu

Implanon

Known as: Nourypharma brand of 3-keto-desogestrel, Organon brand of 3-keto-desogestrel 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Early discontinuation of implanon, a long-acting, reversible contraceptive among reproductive age women in South Africa is a… 
2017
2017
Introduction: Contraceptive discontinuations contribute substantially to the total fertility rate, unwanted pregnancies and… 
2015
2015
Background: Contraceptive use plays an important role in minimizing unintended pregnancies, reduce maternal mortality, and… 
Highly Cited
2011
Highly Cited
2011
ObjectivesStudy was conducted to determine acceptability, efficacy, safety, return of fertility with Implanon.MethodsVolunteers… 
Highly Cited
2009
Highly Cited
2009
ObjectiveTo evaluate the beneficial effects of Implanon on pelvic pain in women with pelvic congestion syndrome (PCS). The… 
2008
2008
Abstract Our study has shown that ultrasound-guided localisation and removal of Implanon™ rods is safe, practical and highly… 
Highly Cited
2004
Highly Cited
2004
Design A multicenter, retrospective study of the single-rod contraceptive implant, Implanon® (NV Organon, Oss, The Netherlands… 
Highly Cited
2000
Highly Cited
2000
ABSTRACT Implanon®, a novel contraceptive implant containing the progestogen, etonogestrel (68 mg), provides highly effective… 
Review
1999
Review
1999
This paper compares current clinical trials experience of Implanon with that of Norplant the other implantable progestogen…